Pindolol (versus unexposed) updated on 12-17-2024

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)--0 study-
Major congenital malformations--0 study-
Minor congenital malformations--0 study-
Neural Tube Defects5.80 [1.29, 26.14]-1 study1,20212not evaluable ROB11.08 [1.89; .]

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Low birth weight (< 2500g)0.93 [0.28, 3.06]-1 study1823not evaluable ROB-
Preterm (< 37 weeks)1.20 [0.31, 4.69]-1 study1123not evaluable ROB-
Small for gestational age (weight)2.11 [0.34, 12.86]-1 study623not evaluable ROB-

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Caesarean1.35 [0.41, 4.46]-1 study1823not evaluable ROB-

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Low Apgar score (< 7) (NOS)0.60 [0.09, 4.01]-1 study523not evaluable ROB-
Neonatal hypoglycemia0.45 [0.04, 5.40]-1 study323not evaluable ROB-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Perinatal death0.96 [0.02, 50.34]-1 study23not evaluable ROB-

Hide endpoints reported in only one study ...